Skip to main content

Table 2 Participant characteristics by cohort (at start of stage; some participants included in several cohorts if progressing)

From: Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set

 

CN

MCI due to AD

Mild AD dementia

Moderate AD dementia

Severe AD dementia

Total (unique participants, at study entry)

Total (overlapping cohorts, at start of stage)

n = 11,458

n = 937

n = 522

n = 457

n = 85

n = 12,414

n = 13,459

Age at first visit (including pre-index visits)

Mean (SD)

70.4 (9.15)

75.6 (7.78)

75.5 (7.97)

75.2 (7.64)

73.9 (8.50)

70.8 (9.14)

71.2 (9.14)

Median (Q1, Q3)

70.0 (65.0, 77.0)

76.0 (71.0, 81.0)

76.0 (71.0, 81.0)

75.0 (71.0, 80.0)

75.0 (69.0, 80.0)

71.0 (65.0, 77.0)

71.0 (65.0, 78.0)

Min, Max

38.0, 104

41.0, 102

46.0, 96.0

46.0, 97.0

46.0, 91.0

38.0, 104

38.0, 104

Age at study entry (index visit)

Mean (SD)

70.5 (9.07)

79.2 (8.05)

78.0 (8.22)

79.0 (8.06)

79.1 (9.07)

71.0 (9.17)

71.7 (9.42)

Median (Q1, Q3)

70.0 (65.0, 77.0)

80.0 (74.0, 85.0)

79.0 (73.0, 84.0)

79.0 (74.0, 85.0)

80.0 (74.0, 85.0)

71.0 (65.0, 77.0)

72.0 (65.0, 78.0)

Min, Max

50.0, 104

51.0, 103

50.0, 97.0

50.0, 98.0

53.0, 96.0

50.0, 104

50.0, 104

Sex, n (%)

Male

3877 (33.8)

390 (41.6)

245 (46.9)

223 (48.8)

40 (47.1)

4337 (34.9)

4775 (35.5)

Female

7581 (66.2)

547 (58.4)

277 (53.1)

234 (51.2)

45 (52.9)

8077 (65.1)

8684 (64.5)

BMI, n (%)

Normal or healthy weight

3685 (32.2)

358 (38.2)

216 (41.4)

195 (42.7)

34 (40.0)

4045 (32.6)

4488 (33.3)

Underweight

122 (1.1)

20 (2.1)

13 (2.5)

9 (2.0)

4 (4.7)

144 (1.2)

168 (1.2)

Overweight

4073 (35.5)

329 (35.1)

197 (37.7)

160 (35.0)

28 (32.9)

4442 (35.8)

4787 (35.6)

Obese

2941 (25.7)

148 (15.8)

66 (12.6)

58 (12.7)

8 (9.4)

3077 (24.8)

3221 (23.9)

Missing

637 (5.6)

82 (8.8)

30 (5.7)

35 (7.7)

11 (12.9)

706 (5.7)

795 (5.9)

Race, n (%)

White

9286 (81.0)

790 (84.3)

453 (86.8)

370 (81.0)

69 (81.2)

10,089 (81.3)

10,968 (81.5)

Black or African American

1668 (14.6)

114 (12.2)

51 (9.8)

60 (13.1)

11 (12.9)

1775 (14.3)

1904 (14.1)

American Indian or Alaska Native

77 (0.7)

2 (0.2)

0 (0)

1 (0.2)

0 (0)

80 (0.6)

80 (0.6)

Native Hawaiian or

Other Pacific Islander

9 (0.1)

0 (0)

0 (0)

1 (0.2)

1 (1.2)

10 (0.1)

11 (0.1)

Asian

272 (2.4)

21 (2.2)

12 (2.3)

16 (3.5)

3 (3.5)

298 (2.4)

324 (2.4)

Other

84 (0.7)

5 (0.5)

5 (1.0)

5 (1.1)

1 (1.2)

95 (0.8)

100 (0.7)

Unknown

62 (0.5)

5 (0.5)

1 (0.2)

4 (0.9)

0 (0)

67 (0.5)

72 (0.5)

Hispanic/Latino ethnicity, n (%)

No

10,636 (92.8)

871 (93.0)

497 (95.2)

423 (92.6)

79 (92.9)

11,520 (92.8)

12,506 (92.9)

Yes

767 (6.7)

64 (6.8)

24 (4.6)

31 (6.8)

5 (5.9)

836 (6.7)

891 (6.6)

Unknown

55 (0.5)

2 (0.2)

1 (0.2)

3 (0.7)

1 (1.2)

58 (0.5)

62 (0.5)

Years of education

Mean (SD)

15.9 (2.94)

15.7 (3.33)

15.5 (3.00)

15.0 (3.35)

15.5 (2.92)

15.9 (2.98)

15.8 (2.99)

Median (Q1, Q3)

16.0 (14.0, 18.0)

16.0 (14.0, 18.0)

16.0 (13.0, 18.0)

16.0 (12.0, 18.0)

16.0 (13.0, 18.0)

16.0 (14.0, 18.0)

16.0 (14.0, 18.0)

Min, Max

0, 29.0

0, 28.0

6.00, 30.0

1.00, 24.0

8.00, 20.0

0, 30.0

0, 30.0

Missing

63 (0.5)

5 (0.5)

1 (0.2)

1 (0.2)

0 (0)

63 (0.5)

70 (0.5)

More than 12 years of education, n (%)

12 years or less

1815 (15.8)

179 (19.1)

120 (23.0)

128 (28.0)

17 (20.0)

2048 (16.5)

2259 (16.8)

More than 12 years

9580 (83.6)

753 (80.4)

401 (76.8)

328 (71.8)

68 (80.0)

10,303 (83.0)

11,130 (82.7)

Missing

63 (0.5)

5 (0.5)

1 (0.2)

1 (0.2)

0 (0)

63 (0.5)

70 (0.5)

Type of residence, n (%)

Single- or multi-family private residence

(apartment, condo, house)

10,697 (93.4)

813 (86.8)

466 (89.3)

400 (87.5)

67 (78.8)

11,549 (93.0)

12,443 (92.5)

Retirement community or independent group living

538 (4.7)

85 (9.1)

41 (7.9)

35 (7.7)

11 (12.9)

603 (4.9)

710 (5.3)

Institutionalized

37 (0.3)

12 (1.3)

9 (1.7)

22 (4.8)

7 (8.2)

53 (0.4)

87 (0.6)

Other or unknown

186 (1.6)

27 (2.9)

6 (1.1)

0 (0)

0 (0)

209 (1.7)

219 (1.6)

Currently smoking, n (%)

No

10,917 (95.3)

580 (61.9)

413 (79.1)

318 (69.6)

65 (76.5)

11,640 (93.8)

12,293 (91.3)

Yes

445 (3.9)

15 (1.6)

6 (1.1)

4 (0.9)

0 (0)

460 (3.7)

470 (3.5)

Missing

96 (0.8)

342 (36.5)

103 (19.7)

135 (29.5)

20 (23.5)

314 (2.5)

696 (5.2)

Alcohol abuse, n (%)

Absent

11,002 (96.0)

572 (61.0)

410 (78.5)

309 (67.6)

61 (71.8)

11,710 (94.3)

12,354 (91.8)

Recent/active

47 (0.4)

3 (0.3)

1 (0.2)

4 (0.9)

1 (1.2)

51 (0.4)

56 (0.4)

Remote/inactive

329 (2.9)

16 (1.7)

8 (1.5)

9 (2.0)

3 (3.5)

354 (2.9)

365 (2.7)

Missing

80 (0.7)

346 (36.9)

103 (19.7)

135 (29.5)

20 (23.5)

299 (2.4)

684 (5.1)

APOE status, n (%)

No ε4 allele

6636 (57.9)

530 (56.6)

183 (35.1)

156 (34.1)

32 (37.6)

7009 (56.5)

7537 (56.0)

One or two copies of ε4 allele

2945 (25.7)

323 (34.5)

303 (58.0)

273 (59.7)

48 (56.5)

3441 (27.7)

3892 (28.9)

Missing

1877 (16.4)

84 (9.0)

36 (6.9)

28 (6.1)

5 (5.9)

1964 (15.8)

2030 (15.1)

Presence or history of CAD, n (%)

No

10,909 (95.2)

856 (91.4)

487 (93.3)

424 (92.8)

78 (91.8)

11,790 (95.0)

12,754 (94.8)

Yes

527 (4.6)

81 (8.6)

35 (6.7)

33 (7.2)

7 (8.2)

602 (4.8)

683 (5.1)

Missing

22 (0.2)

0 (0)

0 (0)

0 (0)

0 (0)

22 (0.2)

22 (0.2)

Presence or history of CVD, n (%)

No

10,910 (95.2)

871 (93.0)

481 (92.1)

422 (92.3)

78 (91.8)

11,801 (95.1)

12,762 (94.8)

Yes

546 (4.8)

66 (7.0)

41 (7.9)

35 (7.7)

7 (8.2)

611 (4.9)

695 (5.2)

Missing

2 (0.0)

0 (0)

0 (0)

0 (0)

0 (0)

2 (0.0)

2 (0.0)

CDR-GS at index date

       

Mean (SD)

0 (0)

0.415 (0.188)

0.662 (0.246)

0.914 (0.402)

1.78 (0.629)

0.0473 (0.181)

0.0968 (0.284)

Median (Q1, Q3)

0 (0, 0)

0.500 (0.500, 0.500)

0.500 (0.500, 1.00)

1.00 (0.500, 1.00)

2.00 (1.00, 2.00)

0 (0, 0)

0 (0, 0)

Min, Max

0, 0

0, 0.500

0.500, 2.00

0.500, 3.00

0.500, 3.00

0, 2.00

0, 3.00

MMSE/MoCA at index date

Mean (SD)

29.1 (1.38)

27.7 (2.16)

23.9 (1.66)

19.8 (3.15)

12.8 (5.03)

28.7 (2.09)

28.4 (2.81)

Median (Q1, Q3)

30.0 (29.0, 30.0)

28.0 (27.0, 29.0)

24.0 (23.0, 25.0)

20.0 (18.0, 22.0)

14.0 (9.00, 17.0)

29.0 (28.0, 30.0)

29.0 (28.0, 30.0)

Min, Max

16.0, 30.0

18.0, 30.0

21.0, 26.0

10.0, 26.0

2.00, 20.0

4.00, 30.0

2.00, 30.0

Missing

222 (1.9)

56 (6.0)

0 (0)

0 (0)

0 (0)

239 (1.9)

278 (2.1)

FAQ score at index date

Mean (SD)

0.205 (1.20)

1.95 (3.22)

9.63 (6.14)

16.5 (7.91)

26.7 (4.09)

0.833 (3.18)

1.44 (4.67)

Median (Q1, Q3)

0 (0, 0)

0 (0, 2.50)

9.00 (4.44, 14.0)

17.0 (10.0, 23.0)

28.0 (25.0, 30.0)

0 (0, 0)

0 (0, 0)

Min, Max

0, 30.0

0, 19.0

0, 23.0

0, 30.0

7.50, 30.0

0, 30.0

0, 30.0

Missing

349 (3.0)

31 (3.3)

0 (0)

1 (0.2)

0 (0)

362 (2.9)

381 (2.8)

NPI-Q at index date

Mean (SD)

0.632 (1.53)

1.54 (2.63)

2.58 (2.47)

4.82 (4.50)

9.98 (6.55)

0.812 (1.86)

0.972 (2.21)

Median (Q1, Q3)

0 (0, 1.00)

0 (0, 2.00)

2.00 (0, 4.00)

3.00 (1.00, 7.00)

9.00 (5.00, 14.0)

0 (0, 1.00)

0 (0, 1.00)

Min, Max

0, 26.0

0, 20.0

0, 12.0

0, 23.0

0, 28.0

0, 26.0

0, 28.0

AD biomarker positive, n (%)

No

732 (6.4)

31 (3.3)

6 (1.1)

12 (2.6)

1 (1.2)

754 (6.1)

782 (5.8)

Yes

210 (1.8)

47 (5.0)

45 (8.6)

42 (9.2)

6 (7.1)

289 (2.3)

350 (2.6)

Missing

10,516 (91.8)

859 (91.7)

471 (90.2)

403 (88.2)

78 (91.8)

11,371 (91.6)

12,327 (91.6)

Number of visits (in this stage)

Mean (SD)

3.81 (3.16)

3.24 (2.53)

1.90 (1.28)

2.45 (1.54)

1.96 (1.36)

3.72 (3.11)

3.64 (3.06)

Median (Q1, Q3)

3.00 (1.00, 5.00)

2.00 (1.00, 4.00)

1.00 (1.00, 2.00)

2.00 (1.00, 3.00)

1.00 (1.00, 3.00)

3.00 (1.00, 5.00)

3.00 (1.00, 5.00)

Min, Max

1.00, 16.0

1.00, 14.0

1.00, 10.0

1.00, 11.0

1.00, 7.00

1.00, 16.0

1.00, 16.0

Number of visits (overall)

Mean (SD)

4.93 (3.55)

7.29 (3.44)

5.65 (2.75)

6.28 (2.81)

6.74 (2.46)

4.98 (3.51)

5.18 (3.55)

Median (Q1, Q3)

4.00 (2.00, 7.00)

7.00 (4.00, 10.0)

5.00 (4.00, 7.00)

6.00 (4.00, 8.00)

7.00 (5.00, 8.00)

4.00 (2.00, 7.00)

4.00 (2.00, 7.00)

Min, Max

1.00, 16.0

2.00, 16.0

2.00, 15.0

2.00, 15.0

2.00, 14.0

1.00, 16.0

1.00, 16.0

  1. AD Alzheimer's disease, APOE Apolipoprotein E, BMI Body mass index, CAD Coronary artery disease, CDR-GS Clinical Dementia Rating – Global Score; CN Cognitively normal, CVD Cerebrovascular disease, FAQ Functional Activities Questionnaire, MCI Mild cognitive impairment, MMSE, Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, NPI-Q Neuropsychiatric Inventory Questionnaire, Q1 First quartile, Q3 Third quartile, SD Standard deviation